Suchergebnisse - "Bakris, George"

PubPharm (314)

1

RNA Interference With Zilebesiran for Mild to Moderate Hypertension : The KARDIA-1 Randomized Clinical Trial

enthalten in: JAMA | 2024

von Bakris, G. | Saxena, M. | Gupta, A. | +109

CommentIn: JAMA. 2024 Mar 5;331(9):733-735. - PMID 38363578

2

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis

enthalten in: Annals of internal medicine | 2023

von Agarwal, R. | Tu, W. | Farjat, A. | +112

3

Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease : A joint analysis of randomized controlled clinical trials

enthalten in: Diabetes, obesity & metabolism | 2023

von Heerspink, H. | Vart, P. | Jongs, N. | +10

4

Managing Phosphate Burden in Patients Receiving Dialysis : Beyond Phosphate Binders and Diet

enthalten in: Kidney360 | 2023

von Kalantar-Zadeh, K. | Forfang, D. | Bakris, G. | +3

5

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone : Post hoc analysis of the FIDELITY study

enthalten in: Diabetes, obesity & metabolism | 2023

von Rossing, P. | Anker, S. | Filippatos, G. | +12

6

Executive Summary : Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

enthalten in: Diabetes care | 2023

von Sacks, D. | Arnold, M. | Bakris, G. | +6

7

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

enthalten in: Diabetes care | 2023

von Sacks, D. | Arnold, M. | Bakris, G. | +6

8

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Rossing, P. | Baeres, F. | Bakris, G. | +11

ErratumIn: Nephrol Dial Transplant. 2023 Nov 30;:. - PMID 38033315

9

The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus : A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials

enthalten in: Diabetes, obesity & metabolism | 2023

von Kang, A. | Smyth, B. | Neuen, B. | +16

10

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

enthalten in: Clinical chemistry | 2023

von Sacks, D. | Arnold, M. | Bakris, G. | +6

CommentIn: Clin Chem. 2023 Aug 2;69(8):788-790. - PMID 37473454

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]